Berry-Kravis Elizabeth M, Zhou Lili, Rand Casey M, Weese-Mayer Debra E
Department of Neurology, Rush University Medical Center, Chicago, IL, USA.
Am J Respir Crit Care Med. 2006 Nov 15;174(10):1139-44. doi: 10.1164/rccm.200602-305OC. Epub 2006 Aug 3.
Congenital central hypoventilation syndrome (CCHS), a unique disorder of respiratory control associated with Hirschsprung disease (HSCR) and tumors of neural crest origin, results from polyalanine repeat expansion mutations in the paired-like homeobox (PHOX)2B gene in more than 90% of cases, and alternative PHOX2B mutations in remaining cases.
To characterize CCHS-associated nonpolyalanine repeat mutations in PHOX2B, evaluate genotype-phenotype relationships, and compare clinical features of CCHS in cases with nonpolyalanine repeat mutations to those with polyalanine expansion mutations.
DNA from probands was analyzed by polymerase chain reaction for the common polyalanine repeat expansion. If no expansion was present, coding regions and intron-exon boundaries of PHOX2B were sequenced. When possible, parents and siblings were screened for the mutation found in the proband.
Fourteen nonpolyalanine repeat mutations, including missense, nonsense, and frameshift mutations, and 170 polyalanine repeat mutations were identified in 184 CCHS probands. Both incomplete penetrance and parental mosaicism were observed within the family members of probands with nonpolyalanine repeat mutations. Increased prevalence of continuous ventilatory dependence, HSCR, and neural crest tumors was seen in the nonpolyalanine repeat group compared to those with polyalanine repeat mutations.
These data suggest that nonpolyalanine repeat mutations produce more severe disruption of PHOX2B function. Patients carrying these mutations should be evaluated for HSCR and neural crest tumors. Because incomplete penetrance can occur in families of CCHS probands with PHOX2B mutations, genetic screening of appropriate family members is indicated to evaluate reproductive risk and because asymptomatic mutation carriers may be at risk for developing alveolar hypoventilation.
先天性中枢性低通气综合征(CCHS)是一种与先天性巨结肠病(HSCR)及神经嵴起源肿瘤相关的独特呼吸控制障碍疾病,90%以上的病例由配对样同源盒(PHOX)2B基因中的多聚丙氨酸重复扩增突变引起,其余病例存在PHOX2B基因的其他突变。
对PHOX2B基因中与CCHS相关的非多聚丙氨酸重复突变进行特征分析,评估基因型与表型的关系,并比较非多聚丙氨酸重复突变病例与多聚丙氨酸扩增突变病例的CCHS临床特征。
通过聚合酶链反应分析先证者的DNA,检测常见的多聚丙氨酸重复扩增情况。若未发现扩增,则对PHOX2B的编码区及内含子-外显子边界进行测序。可能的情况下,对先证者的父母及兄弟姐妹进行该突变的筛查。
在184例CCHS先证者中,鉴定出14种非多聚丙氨酸重复突变,包括错义突变、无义突变和移码突变,以及170种多聚丙氨酸重复突变。在先证者的家庭成员中,非多聚丙氨酸重复突变者观察到不完全外显率及亲本嵌合现象。与多聚丙氨酸重复突变组相比,非多聚丙氨酸重复突变组持续通气依赖、HSCR及神经嵴肿瘤的患病率更高。
这些数据表明,非多聚丙氨酸重复突变对PHOX2B功能的破坏更为严重。携带这些突变的患者应接受HSCR及神经嵴肿瘤的评估。由于PHOX2B基因突变的CCHS先证者家庭中可能出现不完全外显率,因此应对合适的家庭成员进行基因筛查,以评估生殖风险,因为无症状突变携带者可能有发生肺泡低通气的风险。